TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

K Fujimoto, H Arita, K Satomi, K Yamasaki… - Acta …, 2021 - Springer
Abstract The Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy (cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH …
被引用次数：74 相关文章

[引用][C] TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

K Fujimoto, H Arita, K Satomi, K Yamasaki… - Acta …, 2021 - cir.nii.ac.jp
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse
astrocytic glioma with molecular features of glioblastoma | CiNii Research CiNii 国立情報学 …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

K Fujimoto, H Arita, K Satomi… - Acta …, 2021 - pubmed.ncbi.nlm.nih.gov
The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy
(cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH-wildtype diffuse …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.

K Fujimoto, H Arita, K Satomi, K Yamasaki… - Acta …, 2021 - europepmc.org
A comment on this article appears in" Integrated diagnosis of adult-type glioma according to
2021 World Health Organization classification: Analysis of 184 cases using a custom-made …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

K Fujimoto, H Arita, K Satomi… - Acta …, 2021 - okayama.elsevierpure.com
抄録 The Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy (cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.

K Fujimoto, H Arita, K Satomi, K Yamasaki… - Acta …, 2021 - go.gale.com
The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy
(cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH-wildtype diffuse …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

F Kenji, A Hideyuki, S Kaishi, Y Kai… - Acta …, 2021 - search.proquest.com
Abstract The Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy (cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.

K Fujimoto, H Arita, K Satomi… - Acta …, 2021 - search.ebscohost.com
Abstract The Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy (cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH …

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

K Fujimoto, H Arita, K Satomi… - Acta …, 2021 - okayama.elsevierpure.com
Abstract The Consortium to Inform Molecular and Practical Approaches to CNS Tumor
Taxonomy (cIMPACT-NOW) update 3 recommends that histologic grade II and III IDH …